Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+14.33%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
650
Reduced
1,111
Closed
232
Top Buys
| 1 |
GoDaddy
GDDY
|
+$98.5M |
| 2 |
Morgan Stanley
MS
|
+$78.9M |
| 3 |
AbbVie
ABBV
|
+$67.8M |
| 4 |
Kenvue
KVUE
|
+$65.1M |
| 5 |
GE Aerospace
GE
|
+$61.2M |
Top Sells
| 1 |
Amgen
AMGN
|
+$219M |
| 2 |
Williams Companies
WMB
|
+$149M |
| 3 |
Verizon
VZ
|
+$136M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$123M |
| 5 |
PNC Financial Services
PNC
|
+$97.4M |
Sector Composition
| 1 | Healthcare | 18.2% |
| 2 | Technology | 16.32% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Helmerich & Payne
HP
$1.99B
| $36.7K | ﹤0.01% |
1,013
-166
| -14% | -$6.01K |
|
1677
ACM Research
ACMR
$1.79B
| $36.6K | ﹤0.01% |
1,875
-685
| -27% | -$13.4K |
|
1678
Ecovyst
ECVT
$1.03B
| $36.5K | ﹤0.01% |
3,732
-334
| -8% | -$3.26K |
|
1679
Cytek Biosciences
CTKB
$500M
| $36.4K | ﹤0.01% |
+3,996
| New | +$36.4K |
|
1680
Liberty Latin America Class C
LILAK
$1.57B
| $35.6K | ﹤0.01% |
4,847
-264
| -5% | -$1.94K |
|
1681
Patrick Industries
PATK
$3.72B
| $34.8K | ﹤0.01% |
521
-94
| -15% | -$6.28K |
|
1682
Group 1 Automotive
GPI
$6.14B
| $34.7K | ﹤0.01% |
114
-92
| -45% | -$28K |
|
1683
Athira Pharma
ATHA
$15.1M
| $34.1K | ﹤0.01% |
14,048
-881
| -6% | -$2.14K |
|
1684
Worthington Enterprises
WOR
$3.15B
| $34.1K | ﹤0.01% |
592
-10,533
| -95% | -$606K |
|
1685
Eastman Chemical
EMN
$7.76B
| $33.4K | ﹤0.01% |
372
+11
| +3% | +$988 |
|
|
BBUC
1686
Brookfield Business Corp
BBUC
$2.33B
| $33.1K | ﹤0.01% |
1,423
+1,019
| +252% | +$23.7K |
|
1687
Capital City Bank Group
CCBG
$732M
| $32.6K | ﹤0.01% |
1,108
-136
| -11% | -$4K |
|
1688
Park-Ohio Holdings
PKOH
$309M
| $32.5K | ﹤0.01% |
1,207
+287
| +31% | +$7.74K |
|
|
ITOS
1689
DELISTED
iTeos Therapeutics
ITOS
| $32.2K | ﹤0.01% |
2,944
+2,882
| +4,648% | +$31.6K |
|
1690
National Bank Holdings
NBHC
$1.47B
| $32.2K | ﹤0.01% |
866
-1,191
| -58% | -$44.3K |
|
1691
Summit Therapeutics
SMMT
$14B
| $32.1K | ﹤0.01% |
12,316
-5,561
| -31% | -$14.5K |
|
1692
Acushnet Holdings
GOLF
$4.44B
| $32.1K | ﹤0.01% |
+508
| New | +$32.1K |
|
1693
Crawford & Co Class B
CRD.B
$489M
| $32.1K | ﹤0.01% |
2,451
+895
| +58% | +$11.7K |
|
1694
Olympic Steel
ZEUS
$364M
| $31.9K | ﹤0.01% |
478
-136
| -22% | -$9.07K |
|
1695
Design Therapeutics
DSGN
$378M
| $31.8K | ﹤0.01% |
11,999
+9,126
| +318% | +$24.2K |
|
|
TBI
1696
Trueblue
TBI
$165M
| $31.7K | ﹤0.01% |
2,065
-56,331
| -96% | -$864K |
|
1697
Veeco
VECO
$1.49B
| $31.4K | ﹤0.01% |
1,011
-162
| -14% | -$5.03K |
|
1698
Greif Class B
GEF.B
$2.42B
| $31.1K | ﹤0.01% |
471
-64
| -12% | -$4.23K |
|
1699
Beazer Homes USA
BZH
$749M
| $31.1K | ﹤0.01% |
919
-294
| -24% | -$9.93K |
|
1700
Lyell Immunopharma
LYEL
$253M
| $29.7K | ﹤0.01% |
766
+121
| +19% | +$4.69K |
|